Boston Advisors’s Hologic HOLX Stock Holding History

Boston Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,200	Closed	-$202K	–	651
2016 Q3	$202K	Buy	+5,200	New	+$196K	0.01%	663
2016 Q1	–	Sell	-6,200	Closed	-$240K	–	667
2015 Q4	$240K	Hold	6,200	–	–	0.01%	609
2015 Q3	$243K	Hold	6,200	–	–	0.01%	703
2015 Q2	$236K	Sell	6,200 -4,000	-39%	-$140K	0.01%	627
2015 Q1	$337K	Hold	10,200	–	–	0.01%	556
2014 Q4	$273K	Hold	10,200	–	–	0.01%	497
2014 Q3	$248K	Buy	10,200 +200	+2%	+$5.05K	0.01%	522
2014 Q2	$253K	Hold	10,000	–	–	0.01%	536
2014 Q1	$215K	Sell	10,000 -100	-1%	-$2.16K	0.01%	547
2013 Q4	$226K	Hold	10,100	–	–	0.01%	542
2013 Q3	$209K	Sell	10,100 -1,000	-9%	-$21.3K	0.01%	527
2013 Q2	$214K	Buy	+11,100	New	+$232K	0.01%	506

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Advisors's HOLX Position: Q4 2016 in Review

Boston Advisors sold out of Hologic (HOLX) in Q4 2016, closing a stake of 5,200 shares — an estimated $202K sold.

Boston Advisors first reported a position in HOLX in Q2 2013 and held it in 12 quarters. The position peaked at $337K in Q1 2015. 512 funds tracked by Wall St. Rank hold HOLX as of Q4 2016.

Boston Advisors reported no remaining Hologic position as of Q4 2016 after selling out during the quarter.
Boston Advisors sold 5,200 Hologic shares in Q4 2016, an estimated $202K.
Boston Advisors first reported a position in Hologic in Q2 2013 and held it in 12 quarters.
Boston Advisors's Hologic position peaked at $337K in Q1 2015.
512 funds tracked by Wall St. Rank held Hologic as of Q4 2016.

Based on Boston Advisors's 13F filing for Q4 2016, filed 25 Jan 2017.